Charité BIH Innovation
Charité – Universitätsmedizin Berlin is a leading university hospital in Germany that combines top-tier medicine, innovative medical research, and patient-oriented treatment.
Classification
Profile
Funding
Funding details not yet available.
Combines leading university hospital care with innovative medical research to deliver patient-oriented, high-quality treatment for Berlin and Brandenburg.
Patients in Berlin and Brandenburg requiring acute emergency to specialized medical care, and potentially industry partners for research collaboration.
Generates €2.9 billion in annual turnover through public funding and medical services.
Direct provision of services and institutional presence as a publicly owned entity.
Federal State of Berlin, which wholly owns the organization.
High operational costs associated with maintaining a large-scale university hospital and extensive research infrastructure.
Leading university hospital infrastructure, specialized medical expertise, and integration of clinical care with innovative medical research.
Providing patient-oriented medical care from emergency to specialized treatments, and conducting innovative medical research.
Institutional and service-based relationships serving patients and professionals within the medical community.
Competes with other leading university hospitals in Germany by differentiating through the integration of top-tier clinical care and innovative research.
Need for high-quality, specialized medical care and the integration of cutting-edge research into patient treatment.
- Tiered SME Membership - Create a subscription-based access model to increase recurring cash flow
Are you looking to pivot the current model toward a more commercial SaaS platform (e.g., data-exchange) or keep the focus on service-based a · What is the desired timeline for implementing the tiered membership and data-monetization initiatives? · Do you have specific geographic expansion goals (e.g., EU vs. global) that should be reflected in the
- The information is drawn from official Charité/BIH webpages and recent news releases (2025‑2026) confirming program structures, funding amounts, and partnership networks【1†https://www.charite.de/en/charite/organisation/business_divisions/charite_bih_innovation】【2†https://www.bihealth.org/en/translation/innovation-enabler/charite-bih-innovation】.
- The mixed revenue model (fees, equity, royalties) aligns with best‑practice university technology transfer offices across Europe, indicating a proven, sustainable financial foundation.
Team details not yet available.
No investors recorded yet.